Previous Close | 0.0735 |
Open | 0.0735 |
Bid | 0.0665 x N/A |
Ask | 0.0815 x N/A |
Day's Range | 0.0735 - 0.0735 |
52 Week Range | 0.0455 - 0.1090 |
Volume | |
Avg. Volume | 0 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Mar 29, 2023 - Apr 03, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Today, MedMira Inc. (MedMira) (TSXV:MIR) provides an update on its progress to achieve regulatory approval in Canada for its Reveal® TP (Syphilis) antibody test.
PROVIDENCE, R.I. & HALIFAX, Nova Scotia, February 20, 2023--Maternova gains distribution rights across the U.S. and Latin America for MedMira’s rapid diagnostics for sexually transmitted diseases.
Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the singing of a multinational distribution agreement with Maternova, Inc., Rhode Island, USA.